The influence of smoking on the prevalence of respiratory symptoms among young people
- Authors: Tubekova M.А.1, Bilichenko T.N.1
-
Affiliations:
- Research Institute of Pulmonology of Federal Medico-Biological Agency
- Issue: Vol 10, No 4 (2019)
- Pages: 36-45
- Section: Original Study Articles
- URL: https://journals.rcsi.science/clinpractice/article/view/16162
- DOI: https://doi.org/10.17816/clinpract16162
- ID: 16162
Cite item
Full Text
Abstract
Background. Smoking is a preventable risk factor of chronic respiratory diseases.
Aim. To study the incidence of smoking and assess its impact on the prevalence of respiratory symptoms in the young population.
Methods. Based on the GA2LEN questionnaire, a survey of 1252 residents of one Moscow district aged 15–24 years was conducted (response rate — 85.0%). The statistical analysis was performed using the Statistica software package, version 10; EPINFO, version 7 (WHO).
Results. The incidence of smoking was 13.2% among men and 13.0% among women (p=0.895). Regular smoking in young people is registered from the age of 10 years and older. The intensity of smoking was higher in men than in women. The prevalence of respiratory symptoms in smokers (S) was higher than that in non-smokers (NS). 19.1% of NS and 26.3% (p<0.001) of S among men, as well as 15.9% of NS and 29.5% of S (p<0.001) among women noted wheezing in the chest; 30.3% of S and 19.3% of NS (p<0.001) among men and 33.0% of NS and 38.6% of S (p=0.009) among women experienced symptoms of allergic rhinitis in the last 12 months; 20.3% of NS and 25.0% of S (p=0.012) among men and 18.1% of NS and 27.3% of S (p<0.001) among women had nasal congestion for at least 12 weeks.
Conclusions. The adverse effects of smoking on the respiratory health of young people requires an active prevention to reduce the prevalence of respiratory symptoms and the severity of chronic respiratory diseases.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
M. А. Tubekova
Research Institute of Pulmonology of Federal Medico-Biological Agency
Email: m.tubek@rambler.ru
ORCID iD: 0000-0001-8888-6149
SPIN-code: 9096-6194
науч. сотр. лаборатории клинической эпидемиологии
Russian Federation, MoscowTatiana N. Bilichenko
Research Institute of Pulmonology of Federal Medico-Biological Agency
Author for correspondence.
Email: tbilichenko@yandex.ru
ORCID iD: 0000-0003-3138-3625
Doctor of Medicine, Head of Clinical Epidemiology department
Russian Federation, MoscowReferences
- World Health Organization Global Health Observatory. WHO Report on the Global Tobacco Epidemic 2011: Warning About the Dangers of Tobacco. Geneva, World Health Organization, 2011. Available from: whqlibdoc.who.int/publications/2011/9789240687813_eng.pdf.
- Schroeder SA. New evidence that cigarette smoking remains the most important health hazard. N Engl J Med. 2013;368(4):389–390. doi: 10.1056/NEJMe1213751.
- Bousquet J, Kauffmann F, Demoly P, et al. [GA2LEN (Global Allergy and Asthma European Network) (In French).] Rev Mal Respir. 2009;26(6):577–586. doi: 10.1016/s0761-8425(09)74689-3.
- Bousquet J, Schunemann HJ, Zuberbier T, et al. Development and implementation of guidelines in allergic rhinitis — an ARIA-GA2LEN paper. Allergy. 2010;65(10):1212–1221. doi: 10.1111/j.1398-9995.2010.02480.x.
- Akdis CA, Agache I, ed. Рublished by the European Academy of Allergy and Clinical Immunology. Global Atlas of Asthma; 2013. 180 р. Available from: www. eaaci.org.
- Inis Communication. OUR STORY: Let us introduce ourselves. Available from: www.iniscommunication.com.
- Simpson CR, Hippisley-Cox J, Sheikh A. Trends in the epidemiology of smoking recorded in UK general practice. Br J Gen Pract. 2010;60(572):e121–127. doi: 10.3399/bjgp10X483544.
- From Wikipedia, the free encyclopedia. Smoking rate falls to 17% in Canada. CBC News; 2011. Available from: https://en.wikipedia.org/wiki/Prevalence_of_tobacco_use.
- Centers for Disease Control and Prevention (CDC). State-specific prevalence of cigarette smoking among adults and quitting among persons aged 18–35 years — United States, 2006. MMWR Morb Mortal Wkly Rep. 2007;56(38):993–996.
- Association of European Cancer Leagues. The Tobacco Control Scale 2010 in Europe. Brussels, Association of European Cancer Leagues; 2011. Available from: www.europeancancerleagues; org/images/stories/The_TCS_2010_in_Europe_Final_4.pdf.
- Рекомендации ENSP по лечению табачной зависимости. Всестороннее руководство для осуществления мероприятий и стратегий по лечению табачной зависимости. / Пер. с англ. А.А. Демина, под ред. А.К. Демина. — Европейская сеть по профилактике курения и потребления табака, 2016. — 186 с. [ENSP recommendations for the treatment of tobacco addiction. Comprehensive guidance for implementing interventions and strategies for treating tobacco addiction. Translated from English A.A. Demin, ed by A.K. Demin. European network for smoking and tobacco prevention (ENSP); 2016. 186 р. (In Russ).]
- Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2004;(4):CD000165. doi: 10.1002/14651858.CD000165.pub2.